0
Article |

Silicone-Associated Connective-Tissue Disease: Title and subTitle BreakThe Debate Rages

Neil A. Fenske, MD; Frank B. Vasey, MD
[+] Author Affiliations

Division of Dermatology and Cutaneous Surgery; Division of Rheumatology University of South Florida College of Medicine MDC Box 19 12901 Bruce B. Downs Blvd Tampa, FL 33612


Arch Dermatol. 1993;129(1):97-98. doi:10.1001/archderm.1993.01680220109024
Text Size: A A A
Published online

The current lack of definitive information concerning the relationship of silicone breast implants and rheumatic disease represents a massive failure of industry, government, and medicine. Although it is estimated that two million women have been implant recipients, it is disconcerting that the exact number is unknown. Unfortunately, these women are frightened by the considerable publicity generated by legislative hearings questioning the safety of silicone implants as a newly responsible government now struggles with developing regulations for devices that have been in use for approximately 30 years.

Manufacturers and many plastic surgeons have taken the position that the long-term clinical use of silicone breast implants without obvious evidence of adverse reactions is, by itself, adequate support for the safety of these prostheses. When concerns regarding the safety of these devices surfaced, investigators were chagrined to find that no controlled long-term studies of women with breast implants were published. The best available

REFERENCES

Angel M.  Breast implants: protection or paternalism? N Engl J Med. 1992;;326:1968-1969.
Silver RM, Sahn EE, Allen JO, et al.  Demonstration of silicon in sites of connective-tissue disease in patients with silicone-gel breast implants . Arch Dermatol. 1993;;129:63-68.
Kossovsky N, Heggers JP, Dobson MC.  Bioreactivity of silicone . CRC Crit Rev Biocomp. 1987;;3:53-85.
Goldblum RM, Pelley RP, O'Donell AA, Pyron D, Heggers JP.  Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts . Lancet . 1992;;340:510-513.
Love LA, Weiner SR, Vasey FB, et al.  Clinical and immunogenetic features of women who develop myositis after silicone implants (MASI) . Arthritis Rheum. 1992;;35:S46.
Bridges AJ, Conley C, Wang G, Burns DE, Vasey FB.  A clinical and immunological evaluation of women with silicone breast implants and symptoms of rheumatic disease . Arthritis Rheum. 1992;; 35:S65.
Tenebaum SA, Silveira LH, Martinez-Osuna P, Cuellar ML, Garry RF, Espinoza LR.  Identification of a novel autoantigen recognized in silicone-associated connective tissue disease . Arthritis Rheum. 1992;;35:S73.
Vasey FB, Bocanegra TS, Havice DL, Seleznick MJ, Bridgeford PH, Germain BF.  Silicone associated with connective tissue disease: onset of systemic signs and symptoms after traumatic rupture of silicone gel filled breast implants . Arthritis Rheum. 1992;;35:S242.
Vasey FB, Havice DL, Bocanegra TS, Seleznick MJ, Bridgeford PH, Germain BF.  Clinical manifestations of fifty consecutive women with silicone breast implants and connective tissue disease . Arthritis Rheum. 1992;;35:S212.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Angel M.  Breast implants: protection or paternalism? N Engl J Med. 1992;;326:1968-1969.
Silver RM, Sahn EE, Allen JO, et al.  Demonstration of silicon in sites of connective-tissue disease in patients with silicone-gel breast implants . Arch Dermatol. 1993;;129:63-68.
Kossovsky N, Heggers JP, Dobson MC.  Bioreactivity of silicone . CRC Crit Rev Biocomp. 1987;;3:53-85.
Goldblum RM, Pelley RP, O'Donell AA, Pyron D, Heggers JP.  Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts . Lancet . 1992;;340:510-513.
Love LA, Weiner SR, Vasey FB, et al.  Clinical and immunogenetic features of women who develop myositis after silicone implants (MASI) . Arthritis Rheum. 1992;;35:S46.
Bridges AJ, Conley C, Wang G, Burns DE, Vasey FB.  A clinical and immunological evaluation of women with silicone breast implants and symptoms of rheumatic disease . Arthritis Rheum. 1992;; 35:S65.
Tenebaum SA, Silveira LH, Martinez-Osuna P, Cuellar ML, Garry RF, Espinoza LR.  Identification of a novel autoantigen recognized in silicone-associated connective tissue disease . Arthritis Rheum. 1992;;35:S73.
Vasey FB, Bocanegra TS, Havice DL, Seleznick MJ, Bridgeford PH, Germain BF.  Silicone associated with connective tissue disease: onset of systemic signs and symptoms after traumatic rupture of silicone gel filled breast implants . Arthritis Rheum. 1992;;35:S242.
Vasey FB, Havice DL, Bocanegra TS, Seleznick MJ, Bridgeford PH, Germain BF.  Clinical manifestations of fifty consecutive women with silicone breast implants and connective tissue disease . Arthritis Rheum. 1992;;35:S212.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.